Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
Hot Stocks Free for All !
»
CDED buyout/merger
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is not enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by BigT1: [QB] Well I have never seen evidence of that. I call it as I see it and sometimes I'm right sometimes not. CDED got more news today and ended 25% down. Perhaps it was not the news some wanted to hear for an instant 300% gain but IMHO it was good news. CareDecision Corp. to Merge with Kelly Companies Forming NEXT GENeSYS Corp. Wednesday August 25, 9:28 am ET NEW YORK--(BUSINESS WIRE)--Aug. 25, 2004--CareDecision Corporation (OTCBB:CDED - News): First 12 Months Revenue Expected to Exceed $175 Million To Grow Business Portfolio Through Exclusive Prescription Drug Delivery Programs for 40 Million Minority Americans Merger Creates Estimated $65 Million Market Capitalization Company and Combines: Medical and Lodging Wi-Fi Leader CareDecision Corp. Kelly's Prescription Drug and Wireless Tech. Distribution Companies KCWG Pharmaceutical Solutions CareGeneration, Inc. FutureCom Global Inc. CareDecision Corporation (OTCBB:CDED - News), a leading Wi-Fi PDA technology provider to the lodging and satellite media industries, and the developer of patent-pending technologies for e-health and EMR applications; KCWG Pharmaceutical Solutions, a $100 million-plus wholesale prescription drug distributor; CareGeneration, Inc., an emergent provider of direct mail order distribution of retail prescription medicine for uninsured and under-insured Americans; and FutureCom Global, Inc., a leading developer and distributor of wireless products for the medical and hospitality sectors, and other applications for its product lines of Tablet PCs, PDAs, Prepaid Cellular, and Security Systems, today announced an agreement to merge, with terms based on the recent CareDecision counter-proposal, and subject only to usual and customary closing activities. The union will create a new public company with a projected market capitalization (based on expected post merger prices) of $65 million, NEXT GENeSYS Corp., which is expected to generate $175 million in revenue during the first 12 months following the merger. In addition to growing the combined companies' existing wholesale prescription drug and e-lodging businesses, NEXT GENeSYS Corp. will initially target the 40 million minority Americans without any presently available healthcare focus through a directed campaign, in line with stated goals of both state and federal administrations, which offers prescription support via clinics, physician networks, and wellness checks. Industry analysts estimate this market will exceed $8 billion in 2006, and this merger creates an organization with the technology, capitalization and relationships with medical and government agencies necessary to capture market share. Participating clinics and medical practitioners will be provided wireless handheld devices, utilizing technology and infrastructure primarily developed by CareDecision, to prescribe prescription drugs through the Company's direct mail order fulfillment center. "This merger is the final element in a series of strategic activities initiated over two years ago. In anticipation of such a conclusion we have conducted meetings with government officials, major pharmaceutical companies, and healthcare organizations encompassing more than 25,000 physicians. We have also developed significant infrastructure related to our mail-order pharmacy through wireless technologies," commented Ronald Kelly, the incoming Chairman and Chief Executive Officer of NEXT GENeSYS Corp. "We have basic agreements with multiple minority and other client organizations, providing confidence in our ability to achieve a significant presence in this market. Our ability to couple wireless connectivity solutions for doctors with a state-of-the-art e-pharmacy for direct drug distribution has the capability to revolutionize the way targeted Americans receive medications. We will speed delivery, minimize bureaucracy, and fulfill prescription drugs through our Illinois-based automated e-pharmacy, as we work to streamline the process and carve out a significant market share." Keith Berman, Chief Financial Officer of CareDecision Corp., a nominee for the Board of NEXT GENeSYS Corp., and speaking for the Board of CareDecision, commented, "The current Board is satisfied that we have received fair value based on our recent counter-proposal. This merger combines organizations that are perfectly complementary, reinforcing our key strengths, funding expansion into an underserved healthcare sector, and allowing us flexibility with our ResidenceWare electronic concierge hotel networks by creating vertical integration and communications expertise. We plan a conference call with interested parties in the coming days elaborate on this exciting merger." The convergence of companies couples CareDecision's patents-pending Wi-Fi handheld technology and installed Wi-Fi hotel e-business networks, with the wireless PC and PDA hardware distribution, wholesale and mail order retail drug and medical supply distribution, physician-to-fulfillment networks, and other wireless technology solutions brought into the new company by the Kelly companies. The merger will thus create a unique wireless-centered e-business enterprise strategically positioned to capture significant market share by delivering affordable healthcare and related technology products and services to both consumers and businesses. Mr. Kelly concluded, "Modernizing the healthcare system is a priority for both Presidential candidates, and building upon our existing base of business through this merger will create a significant business force in accomplishing a major delivery system improvement for America's minority, uninsured and under-insured population. Our unique solution, combining the in-house technologies and technology creations, coupled with our capability to distribute prescription drugs to America's poor and under-insured at what will be perceived as discount prices, could eventually allow us to transfer our unique business model and automate the process of prescribing medicine to all Americans." About the "Kelly-affiliated" Companies KCWG's Pharmaceutical Solutions and the current CareGeneration are private entities, both founded and wholly-owned by Ronald R. Kelly. They are both focused upon improved healthcare through more cost-effective delivery of prescription pharmaceuticals. FutureCom Global, Inc. is a private Nevada corporation with approximately four hundred shareholders, and with majority ownership by Mr. Kelly. Currently, FCG concentrates in the development and distribution of a broad array of consumer and business electronics products, focused upon wireless solutions, including PDAs, Tablet PCs, Cellular, and Security Systems comprised of biometric and RFID product lines. About CareDecision Corp. CareDecision Corp is a leading provider of Internet-enhanced PDA devices applicable to healthcare, lodging, and satellite rebroadcast industries. Its proprietary ResidenceWare, MD@Hand and Satelink technologies manage critical data, enhance productivity and e-commerce, and facilitate communication with applications in the healthcare, apartment, hotel/motel and satellite rebroadcast industries I held and tried to buy more shares today but waited to late in day. IMO it will bounce tomorrow AM and then we will see when conference call and further PR's enlighten us to further details. [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2